Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. HitGen's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for HitGen's Dividend Payout Ratio or its related term are showing as below:
SHSE:688222'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.18 Med: 0.74 Max: 1.67
Current: 0.18
During the past 10 years, the highest Dividend Payout Ratio of HitGen was 1.67. The lowest was 0.18. And the median was 0.74.
SHSE:688222's Dividend Payout Ratio is ranked better than 80.6% of 134
companies
in the Biotechnology industry
Industry Median: 0.435
vs SHSE:688222: 0.18
During the past 12 months, HitGen's average Dividends Per Share Growth Rate was 20.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 6.30% per year.
During the past 10 years, the highest 3-Year average Dividends Per Share Growth Rate of HitGen was 6.30% per year. The lowest was 0.00% per year. And the median was 3.15% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
HitGen (SHSE:688222) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
HitGen Dividend Payout Ratio Related Terms
HitGen Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for HitGen's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688222 vs VRTX, REGN, ALNY: Dividend Payout Ratio Comparison
For the Biotechnology subindustry, HitGen's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HitGen Dividend Payout Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, HitGen's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where HitGen's Dividend Payout Ratio falls into.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
HitGen's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HitGen (SHSE:688222) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on HitGen and its competitors. Over the past decade, HitGen's Dividend Payout Ratio has ranged from 0.18 to 1.67. According to the industry distribution chart, HitGen ranks #26 out of 134 companies in the Biotechnology industry, placing it in the top 19.4%.
Is HitGen's Dividend Payout Ratio too high?
HitGen's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.18 to a high of 1.67. Based on the distribution chart, HitGen ranks #26 out of 134 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, HitGen has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HitGen's Dividend Payout Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, HitGen ranks #26 out of 134 companies for Dividend Payout Ratio. This places HitGen in the top 19% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.44. Historically, HitGen's own Dividend Payout Ratio has ranged from 0.18 to 1.67 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Biotechnology company?
The median Dividend Payout Ratio among Biotechnology companies is 0.44, based on 134 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on HitGen and its competitors. For the Biotechnology industry, the median Dividend Payout Ratio is 0.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HitGen's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HitGen stock overvalued right now?
Based on GuruFocus' analysis, HitGen (SHSE:688222) is currently considered Fairly Valued. The stock's GF Value™ is ¥26.07, compared to a current price of ¥28.30 — trading 8.6% above its estimated fair value. The current Dividend Payout Ratio is 0.00. HitGen's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For HitGen (SHSE:688222), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HitGen (SHSE:688222) Overvalued in 2026?
Based on GuruFocus' analysis, HitGen stock appears to be overvalued.
The current stock price of ¥28.30 is trading 8.6% above its estimated GF Value™ of ¥26.07.
GuruFocus considers HitGen to be Fairly Valued.
Key valuation signals for SHSE:688222:
Dividend Payout Ratio: 0.00
GF Value™: ¥26.07 vs. price of ¥28.30 (8.6% above fair value)
No single metric tells the full story. See the SHSE:688222 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HitGen Inc is dedicated to building a world-class biopharmaceutical enterprise. Its mission is to advance human health and quality of life. It provides therapeutic solutions to address unmet medical needs. Centered on its internationally DEL (DNA-encoded Library) technology, the Company has expanded into Fragment-Based Drug Discovery and Structure-Based Drug Design and a suite of complementary platforms based on Oligonucleotide-based Therapeutics, Targeted Proximity Drugs, and Cyclic Peptidomimetics. The group has developed HAILO, a proprietary "DEL+AI+Automation" molecular optimization platform, thereby establishing a distinctive novel molecule discovery engine that delivers both therapeutic molecules and tool molecules to the world-wide pharmaceutical industry.
90GF Score
Get the complete analysis for SHSE:688222
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688222 has been successfully added to your 
